Chemistry:Reposal: Difference between revisions
From HandWiki
(correction) |
(No difference)
|
Latest revision as of 01:14, 6 February 2024
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H18N2O3 |
| Molar mass | 262.309 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]
References
- ↑ "Reposal, A New Hypnotic. I. Pharmacodynamic Activity" (in Danish). Ugeskrift for Laeger 125: 1735–8. December 1963. PMID 14103836.
- ↑ "Reposal, A New Hypnotic. Ii. Clinical Effects" (in Danish). Ugeskrift for Laeger 125: 1739–41. December 1963. PMID 14103837.
- ↑ "The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal)". Acta Pharmacologica et Toxicologica 26 (6): 521–30. 1968. doi:10.1111/j.1600-0773.1968.tb00471.x. PMID 5756387.
 |  |
